Return to Trial Database

HCRN-LYM22-565

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-LYM22-565 being conducted in.

Barbara Ann Karmanos Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

University of Virginia Cancer Center

UT Southwestern Harold C. Simmons Comprehensive Cancer Center